EIX vs KYTX · P/E 7.3, rev $19.32B vs $488.8M cap
Edison International (EIX) versus Kyverna Therapeutics, Inc. Common Stock (KYTX) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
Latest reported EIX revenue for 2025-12-31 was $19.32B. Net income was $4.46B. Revenue was up 9.8% from 2024-12-31 to 2025-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
KYTX does not have a complete income-statement cache yet.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. KYTX currently screens at market cap $488.8M.
Not investment advice. Open the EIX and KYTX stock pages for the full models.
Not investment advice.